关注
Aljosja Rogiers
Aljosja Rogiers
The Royal Marsden NHS Foundation Trust
在 rmh.nhs.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
5992018
Melanoma addiction to the long non-coding RNA SAMMSON
E Leucci, R Vendramin, M Spinazzi, P Laurette, M Fiers, J Wouters, ...
Nature 531 (7595), 518-522, 2016
5532016
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ...
Nature cancer 2 (12), 1305-1320, 2021
1672021
Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth
M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ...
The Journal of clinical investigation 126 (1), 68-84, 2016
1672016
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
CC Bell, KA Fennell, YC Chan, F Rambow, MM Yeung, D Vassiliadis, ...
Nature communications 10 (1), 2723, 2019
1522019
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
A Talebi, J Dehairs, F Rambow, A Rogiers, D Nittner, R Derua, ...
Nature communications 9 (1), 2500, 2018
1182018
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors
CS Higham, E Dombi, A Rogiers, S Bhaumik, S Pans, SEJ Connor, ...
Neuro-oncology 20 (6), 818-825, 2018
1092018
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma
O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ...
Cancer Cell 39 (8), 1135-1149. e8, 2021
962021
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma
S Corre, N Tardif, N Mouchet, HM Leclair, L Boussemart, A Gautron, ...
Nature communications 9 (1), 4775, 2018
912018
A non-coding function of TYRP1 mRNA promotes melanoma growth
D Gilot, M Migault, L Bachelot, F Journé, A Rogiers, E Donnou-Fournet, ...
Nature cell biology 19 (11), 1348-1357, 2017
872017
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
A Fendler, STC Shepherd, L Au, M Wu, R Harvey, AM Schmitt, Z Tippu, ...
The Lancet 399 (10328), 905-907, 2022
772022
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, AM Schmitt, Z Tippu, ...
Cancer Cell 40 (2), 114-116, 2022
672022
Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model
BJ Van der Schueren, A Rogiers, FH Vanmolkot, A Van Hecken, M Depre, ...
Journal of Pharmacology and Experimental Therapeutics 325 (1), 248-255, 2008
642008
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
A Rogiers, IP Da Silva, C Tentori, CA Tondini, JM Grimes, MH Trager, ...
Journal for ImmunoTherapy of Cancer 9 (1), 2021
612021
Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: a potential marker of irreversible thyroid dysfunction?
A Rogiers, P Wolter, KO de Beeck, M Thijs, B Decallonne, P Schöffski
Thyroid 20 (3), 317-322, 2010
522010
Molecular genetic and immunotherapeutic targets in metastatic melanoma
C Melis, A Rogiers, O Bechter, JJ van den Oord
Virchows Archiv 471, 281-293, 2017
252017
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer
A Fendler, STC Shepherd, L Au, M Wu, R Harvey, KA Wilkinson, ...
Cell Reports Medicine 3 (10), 2022
232022
Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination
A Rogiers, P Wolter, O Bechter
Melanoma research 27 (2), 164-167, 2017
232017
Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ...
Cancer discovery 13 (6), 1364-1385, 2023
192023
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases–A multicenter cohort study
CJ Holmberg, L Ny, TJ Hieken, MS Block, MJ Carr, VK Sondak, ...
European Journal of Cancer 169, 210-222, 2022
162022
系统目前无法执行此操作,请稍后再试。
文章 1–20